BRIEF published on 09/18/2024 at 07:35, 2 years 1 month ago Sensorion annonce ses résultats financiers et ses avancées cliniques pour le premier semestre 2024 Essais Cliniques Thérapie Génique Résultats Financiers 2024 Sensorion Thérapies Pour La Perte Auditive
PRESS RELEASE published on 09/18/2024 at 07:30, 2 years 1 month ago Half yearly financial reports and audit reports/limited reviews / Half yearly financial report Sensorion reports 2024 first half results including progress on SENS-501 and SENS-401 programs. Cash position strong at €87m. Future milestones and financial highlights outlined Sensorion Hearing Loss SENS-401 SENS-501 2024 Results
PRESS RELEASE published on 09/18/2024 at 07:30, 2 years 1 month ago Rapports financiers et d'audit semestriels/examens réduits / Rapport financier semestriel Sensorion publie ses résultats du premier semestre 2024 et fait le point sur ses activités. Premières données cliniques de SENS-501 et SENS-401 au Congrès Mondial d'Audiologie Résultats Premier Semestre Audiologie Sensorion Clinique
BRIEF published on 09/12/2024 at 07:35, 2 years 1 month ago Sensorion to Present at 59th Inner Ear Biology Workshop Conference Sensorion Hearing Loss Inner Ear Biology Proteomics
BRIEF published on 09/12/2024 at 07:35, 2 years 1 month ago Sensorion présentera au 59e atelier sur la biologie de l'oreille interne Conference Sensorion Perte Auditive Biologie De L'oreille Interne Protéomique
PRESS RELEASE published on 09/12/2024 at 07:30, 2 years 1 month ago Inside Information / Other news releases Sensorion announces participation in the 59th Annual Inner Ear Biology Workshop in Warsaw, Poland. Presentation on SENS-401 and gene therapy programs Gene Therapy Sensorion Hearing Loss SENS-401 Inner Ear Biology Workshop
PRESS RELEASE published on 09/12/2024 at 07:30, 2 years 1 month ago Informations privilégiées / Autres communiqués Sensorion annonce sa participation à la 59ème conférence annuelle Inner Ear Biology Workshop pour présenter des résultats sur SENS-401 et d'autres thérapies auditives innovantes Sensorion Thérapies Auditives SENS-401 59ème Conférence Biologie Oreille Interne
BRIEF published on 09/02/2024 at 07:35, 2 years 1 month ago Sensorion au Congrès Mondial d’Audiologie 2024 à Paris Thérapie Génique Sensorion Perte Auditive Congrès Mondial D’Audiologie Symposium Médical
BRIEF published on 09/02/2024 at 07:35, 2 years 1 month ago Sensorion at the World Congress of Audiology 2024 in Paris Gene Therapy Sensorion Hearing Loss World Congress Of Audiology Medical Symposium
PRESS RELEASE published on 09/02/2024 at 07:30, 2 years 1 month ago Informations privilégiées / Autres communiqués Sensorion annonce sa participation au Congrès Mondial d’Audiologie en septembre 2024 à Paris et animera un symposium sur les avancées médicales dans le domaine de la perte auditive Paris Sensorion Perte Auditive Congrès Mondial D’Audiologie Avancées Médicales
Published on 10/26/2026 at 13:30, 4 hours 12 minutes ago Stabilis Solutions Announces Third Quarter 2026 Conference Call and Webcast Date
Published on 10/26/2026 at 13:00, 4 hours 42 minutes ago BTU Commences Initial Drill Program on Hubcap Project Adjacent to RPX in Wawa
Published on 10/26/2026 at 12:30, 5 hours 12 minutes ago Longview Capital Announces Voluntary TSXV Delisting
Published on 10/26/2026 at 17:35, 7 minutes ago GEVELOT S.A.: Déclaration hebdomadaire de rachat d'actions 26/10/2026
Published on 10/26/2026 at 17:35, 7 minutes ago GEVELOT S.A.: Weekly declaration of share buybacks – 10/26/2026 (French only)
Published on 10/26/2026 at 17:30, 12 minutes ago FP Markets: Healey's first Budget puts Gilts in focus
Published on 10/26/2026 at 17:15, 27 minutes ago HKSTP Partners with Leading Science and Technology Company Merck to Open a New Chapter in I&T Collaboration
Published on 10/26/2026 at 17:00, 42 minutes ago EQS Group receives validation of its climate targets by the Science Based Targets initiative
Published on 10/26/2026 at 17:30, 12 minutes ago Nombre total de droits de vote et actions composant le capital social au 30 septembre 2026
Published on 10/26/2026 at 17:30, 12 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of September 30, 2026
Published on 10/26/2026 at 11:27, 6 hours 15 minutes ago 261026 BENETEAU Transactions sur actions propres
Published on 10/26/2026 at 07:30, 10 hours 12 minutes ago EURAZEO’S SUPERVISORY BOARD APPOINTS CHRISTOPHE BAVIÈRE AS CHAIRMAN OF THE EXECUTIVE BOARD AND CEO
Published on 10/26/2026 at 07:30, 10 hours 12 minutes ago LE CONSEIL DE SURVEILLANCE D’EURAZEO NOMME M. CHRISTOPHE BAVIERE PRESIDENT DU DIRECTOIRE
